Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity

Digestive and Liver Disease

Volumn 46, Issue 6, 2014, Pages 556-560

  Giorgio, Valentina ^a   Miele, Luca ^b   Principessa, Luigi ^c   Ferretti, Francesca ^a   Villa, Maria Pia ^c   Negro, Valentina ^c   Grieco, Antonio ^b   Alisi, Anna ^a   Nobili, Valerio ^a  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Intestinal permeability; Lactulose mannitol ratio; Lipopolysaccharides; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis

Indexed keywords

LACTULOSE; LIPOPOLYSACCHARIDE; MANNITOL;

ARTICLE; BACTERIAL TRANSLOCATION; BOWEL PERMEABILITY TEST; CASE CONTROL STUDY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIGESTIVE SYSTEM EXAMINATION; DISEASE SEVERITY; ENDOTOXEMIA; FEMALE; HUMAN; INFLAMMATION; INTESTINE MUCOSA PERMEABILITY; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; SCHOOL CHILD; STEATOSIS; CHILDHOOD DISEASE; CLINICAL FEATURE; HUMAN TISSUE; INTESTINAL PERMEABILITY; INTESTINE BIOPSY; INTESTINE EXAMINATION; INTESTINE FUNCTION; INTESTINE PARAMETERS; LACTULOSE MANNITOL RATIO; MEMBRANE PERMEABILITY; PREVALENCE; ADOLESCENT; BLOOD; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PERMEABILITY; SEVERITY OF ILLNESS INDEX;

ADOLESCENT; BACTERIAL TRANSLOCATION; CASE-CONTROL STUDIES; CHILD; FEMALE; HUMANS; INTESTINAL MUCOSA; LACTULOSE; LIPOPOLYSACCHARIDES; MALE; MANNITOL; NON-ALCOHOLIC FATTY LIVER DISEASE; PERMEABILITY; SEVERITY OF ILLNESS INDEX;

EID: 84902550631     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2014.02.010     Document Type: Article

References (19)

1. Wree A., Broderick L., Canbay A., et al. From NAFLD to NASH to cirrhosis-new insights into disease mechanisms. Nature Reviews Gastroenterology and Hepatology 2013, 10:627-636.
2. Miele L., Marrone G., Lauritano C., et al. Gut-liver axis and microbiota in NAFLD: insight pathophysiology for novel therapeutic target. Current Pharmaceutical Design 2013, 19:5314-5324.
3. Frasinariu O.E., Ceccarelli S., Alisi A., et al. Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Digestive and Liver Disease 2013, 45:543-551.
4. Roh Y.S., Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. Journal of Gastroenterology and Hepatology 2013, 28:38.
5. Miele L., Valenza V., La Torre G., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology 2009, 49:1877-1887.
6. Lostia A.M., Lionetto L., Principessa L., et al. A liquid chromatography/mass spectrometry method for the evaluation of intestinal permeability. Clinical Biochemistry 2008, 41:887-892.
7. Dastych M., Dastych M., Novotná H., et al. Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn's disease. Digestive Diseases and Sciences 2008, 53:2789-2792.
8. Matthews D.R., Hosker J.P., Rudenski A.S., et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
9. Matsuda M., DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999, 22:1462-1470.
10. Ogden C.L., Kuczmarski R.J., Flegal K.M., et al. Centers for disease control and prevention 2000 growth charts for the United States: improvements to the 1977 national center for health statistics version. Pediatrics 2002, 109:45-60.
11. Kleiner D.E., Brunt E.M., Van Natta M., et al. Nonalcoholic steatohepatitis clinical research network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
12. Brunt E.M., Kleiner D.E., Wilson L.A., et al. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 2011, 53:810-820.
13. Machado M.V., Cortez-Pinto H. Gut microbiota and nonalcoholic fatty liver disease. Annals of Hepatology 2012, 11:440-449.
14. Henao-Mejia J., Elinav E., Jin C., et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 2012, 482:179-185.
15. Benjamin J., Singla V., Arora I., et al. Intestinal permeability and complications in liver cirrhosis: A prospective cohort study. Hepatology Research 2013, 43:200-207.
16. Assimakopoulos S.F., Tsamandas A.C., Tsiaoussis G.I., et al. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability. European Journal of Clinical Investigation 2012, 42:439-446.
17. Gäbele E., Dostert K., Hofmann C., et al. DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH. Journal of Hepatology 2011, 55:1391-1399.
18. Spruss A., Kanuri G., Wagnerberger S., Haub S., Bischoff S.C., Bergheim I. Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009, 50:1094-1104.
19. Li D.Y., Yang M., Edwards S., Ye S.Q. Nonalcoholic fatty liver disease: for better or worse, blame the gut microbiota. Journal of Parenteral and Enteral Nutrition 2013, 37:787-793.